| 3201 |
Apheresis |
Allogeneic |
Post–Polycythemia Vera Myelofibrosis (Post-Pv Mf) |
Hematology |
2022 |
Standard Therapy |
Poland |
48 |
| 3202 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
65 |
| 3203 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
65 |
| 3204 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
58 |
| 3205 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
39 |
| 3206 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
67 |
| 3207 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
37 |
| 3208 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
69 |
| 3209 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 3210 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
66 |
| 3211 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
70 |
| 3212 |
Apheresis |
Allogeneic |
Primary Refractory T-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 3213 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
58 |
| 3214 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
51 |
| 3215 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
53 |
| 3216 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
45 |
| 3217 |
Apheresis |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
3 months |
| 3218 |
Apheresis |
Allogeneic |
Sezary Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
59 |
| 3219 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 3220 |
Apheresis |
Allogeneic |
T-Cell Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
37 |
| 3221 |
Apheresis |
Allogeneic |
T-Cell Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
30 |
| 3222 |
Apheresis |
Allogeneic |
T-Cell Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
46 |
| 3223 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
52 |
| 3224 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
51 |
| 3225 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
52 |
| 3226 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
60 |
| 3227 |
Apheresis |
Autologous |
Testicular Cancer |
Hematology |
2022 |
Standard Therapy |
Germany |
48 |
| 3228 |
Apheresis |
Allogeneic |
Thalassemia Major |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 3229 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
60,11 |
| 3230 |
Adipose Tissue |
Autologous |
Internal Damage To The Knee Joint |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
41,9 |
| 3231 |
Adipose Tissue |
Autologous |
Internal Damage To The Knee Joint |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
30,1 |
| 3232 |
Adipose Tissue |
Autologous |
Internal Damage To The Knee Joint |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
53 |
| 3233 |
Skeletal Muscle |
Allogeneic – Related |
Duchenne Muscular Dystrophy (DMD) |
Genetic disorder |
2021 |
Experimental Therapy |
Poland |
7 |
| 3234 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2021 |
Experimental Therapy |
Poland |
7,8 |
| 3235 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Myeloid Leukemia – Transplantation Failure |
Hematology |
2021 |
Experimental Therapy |
Poland |
13,5 |
| 3236 |
Cord Tissue |
Allogeneic – Unrelated |
Ags (Autism + Epilepsy) |
Neurology |
2021 |
Experimental Therapy |
Poland |
13,3 |
| 3237 |
Cord Tissue |
Allogeneic – Unrelated |
Ags (Autism + Epilepsy) |
Neurology |
2021 |
Experimental Therapy |
Romania |
13 |
| 3238 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
74,4 |
| 3239 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
64,11 |
| 3240 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
70,11 |
| 3241 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
59,2 |
| 3242 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
47,9 |
| 3243 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3244 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3245 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
66,8 |
| 3246 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
28,4 |
| 3247 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3248 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3249 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3250 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3251 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3252 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3253 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3254 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3255 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3256 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3257 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
54,11 |
| 3258 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3259 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3260 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3261 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3262 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
55,2 |
| 3263 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3264 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
70,5 |
| 3265 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
54,2 |
| 3266 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
58,11 |
| 3267 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3268 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3269 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Clinical Trial ALSTEM |
Poland |
no data |
| 3270 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
62,4 |
| 3271 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2021 |
Experimental Therapy |
Poland |
74,6 |
| 3272 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
4 |
| 3273 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
9,2 |
| 3274 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
10 |
| 3275 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
4,6 |
| 3276 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
15,5 |
| 3277 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
no data |
| 3278 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
7,11 |
| 3279 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
6,9 |
| 3280 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
4,9 |
| 3281 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
12,5 |
| 3282 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
12,1 |
| 3283 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
7,5 |
| 3284 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
8,7 |
| 3285 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
11,1 |
| 3286 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
5,3 |
| 3287 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
4,5 |
| 3288 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
8,11 |
| 3289 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2021 |
Experimental Therapy |
Poland |
6,4 |
| 3290 |
Cord Tissue |
Allogeneic – Unrelated |
Bone Marrow Transplant Rejection; Graft Versus Host Disease |
Hematology |
2021 |
Experimental Therapy |
Poland |
6,8 |
| 3291 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebellar Ataxia |
Neurology |
2021 |
Experimental Therapy |
Poland |
59 |
| 3292 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2021 |
Experimental Therapy |
Poland |
3,1 |
| 3293 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2021 |
Experimental Therapy |
Poland |
7,1 |
| 3294 |
Cord Tissue |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2021 |
Experimental Therapy |
Poland |
5 |
| 3295 |
Cord Tissue |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2021 |
Experimental Therapy |
Poland |
17 |
| 3296 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2021 |
Experimental Therapy |
Poland |
6,6 |
| 3297 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2021 |
Experimental Therapy |
Poland |
6,1 |
| 3298 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2021 |
Experimental Therapy |
Poland |
1,9 |
| 3299 |
Cord Tissue |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2021 |
Experimental Therapy |
Poland |
11 |
| 3300 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2021 |
Experimental Therapy |
Poland |
7,11 |